Work

Debio 1562M | Drug Description

Year: 2025

Type: article

Abstract: Debio 1562M is a next-generation investigational antibody-drug conjugate (ADC) consisting of a humanized monoclonal antibody (K7153B[huCD37-3] or naratuximab) directed against CD37 and conjugated to a peptidic cleavable linker (Multilink™)* bearing a maytansinoid cytotoxic payload (DM1).

Source: ADC Review / Journal of Antibody-drug Conjugates

DOI: 10.14229/jadc.2025.02.12.001

Author: Peter Hofland

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4407634359

FWCI:

Cites: 20

Cited by:

Related to: 10